the value of flt3 inhibitors in aml and focus for future trial designs
Published 1 year ago • 147 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
3:04
ff-10101-01: a novel flt3 inhibitor for r/r aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
2:44
phase i/ii study of novel flt3 inhibitor hm43239 in r/r aml
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
3:10
novel aml treament approaches
-
2:19
novel potent and selective flt3 inhibitors
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:30
combinations with flt3 inhibitors: the way forward for aml treatment
-
2:20
best treatment strategy for flt3 itd aml
-
0:51
unmet needs in front-line therapy for patients with flt3-mutated aml
-
2:15
novel agents in trials for aml: quizartinib and gilteritinib
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
2:05
phase iii trial of azacitidine and gilteritinib in flt3 mutant aml
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:01
novel treatment paradigms for aml at ash 2021
-
2:29
flt3 inhibitors as maintenance therapy in aml